Analysis of Johnson & Johnson
The pharmaceutical industry comprises establishments primarily engaged in manufacturing drugs, medicines and related products for human or animal use. Establishments in this industry may undertake one or more of several processes, including basic processes, such as chemical synthesis, fermentation, distillation and solvent extraction; grading, grinding and milling; and packaging in forms suitable for internal and external use, such as tablets, vials, ampoules and ointments.
Johnson & Johnson is the world's leading manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and medical devices and diagnostics markets. The company's products range from baby care, first aid and hospital products to prescription pharmaceuticals, diagnostics and products relating to family planning, dermatology and feminine hygiene.
Headquartered in New Brunswick, N.J Johnson & Johnson operates in 57 countries around the world employing 110,600 employees and selling products in more than 175 countries.
Aruvian's R'search presents Analysis of Johnson & Johnson. A complete and comprehensive analysis of Johnson & Johnson, the world's leading manufacturer of health care products, includes an overview of the pharmaceutical industry in the United States, a PEST Framework Analysis of the US Pharmaceutical Industry, and then moves on to analyzing the company itself.
Company analysis from Aruvian includes a history of Johnson & Johnson, a business segment analysis of the segments Johnson & Johnson operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors namely Merck & Co Inc, Novartis AG, and Procter & Gamble.
A financial analysis of Johnson & Johnson is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Johnson & Johnson completes this in-depth company analysis.
Johnson & Johnson is the world's leading manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and medical devices and diagnostics markets. The company's products range from baby care, first aid and hospital products to prescription pharmaceuticals, diagnostics and products relating to family planning, dermatology and feminine hygiene.
Headquartered in New Brunswick, N.J Johnson & Johnson operates in 57 countries around the world employing 110,600 employees and selling products in more than 175 countries.
Aruvian's R'search presents Analysis of Johnson & Johnson. A complete and comprehensive analysis of Johnson & Johnson, the world's leading manufacturer of health care products, includes an overview of the pharmaceutical industry in the United States, a PEST Framework Analysis of the US Pharmaceutical Industry, and then moves on to analyzing the company itself.
Company analysis from Aruvian includes a history of Johnson & Johnson, a business segment analysis of the segments Johnson & Johnson operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors namely Merck & Co Inc, Novartis AG, and Procter & Gamble.
A financial analysis of Johnson & Johnson is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Johnson & Johnson completes this in-depth company analysis.
A. EXECUTIVE SUMMARY
B. LOOKING AT THE INDUSTRY
B.1 Industry Definition
B.2 Brief Profile of the US Pharmaceutical Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective
C. US PHARMACEUTICAL INDUSTRY – PEST FRAMEWORK ANALYSIS
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. LOOKING AT JOHNSON & JOHNSON
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.4 Corporate Hierarchy
D.5 Organizational Divisions
D.6 Profiling the Key Executives
D.7 Products & Services
D.8 Corporate Strategies
D.9 Recently in the News
E. LOOKING AT BUSINESS
E.1 Business Segments
E.2 Geographical Segments
E.3 Mergers & Acquisitions Profile
E.4 Company Subsidiaries
F. JOHNSON & JOHNSON: SWOT FRAMEWORK ANALYSIS
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome
G. PROFILING THE COMPETITION
G.1 Merck & Co Inc
G.2 Novartis AG
G.3 Procter & Gamble
H. JOHNSON & JOHNSON - FINANCIAL ANALYSIS
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
I. JOHNSON & JOHNSON: FUTURE PERSPECTIVE
J. APPENDIX
K. GLOSSARY OF TERMS
B. LOOKING AT THE INDUSTRY
B.1 Industry Definition
B.2 Brief Profile of the US Pharmaceutical Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective
C. US PHARMACEUTICAL INDUSTRY – PEST FRAMEWORK ANALYSIS
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. LOOKING AT JOHNSON & JOHNSON
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.4 Corporate Hierarchy
D.5 Organizational Divisions
D.6 Profiling the Key Executives
D.7 Products & Services
D.8 Corporate Strategies
D.9 Recently in the News
E. LOOKING AT BUSINESS
E.1 Business Segments
E.2 Geographical Segments
E.3 Mergers & Acquisitions Profile
E.4 Company Subsidiaries
F. JOHNSON & JOHNSON: SWOT FRAMEWORK ANALYSIS
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome
G. PROFILING THE COMPETITION
G.1 Merck & Co Inc
G.2 Novartis AG
G.3 Procter & Gamble
H. JOHNSON & JOHNSON - FINANCIAL ANALYSIS
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
I. JOHNSON & JOHNSON: FUTURE PERSPECTIVE
J. APPENDIX
K. GLOSSARY OF TERMS
